Understanding the path to diagnosis for stage I endometrial cancer is crucial for timely and effective care. This early-stage cancer is highly treatable when identified promptly, making proper diagnostic procedures essential for the best possible outcomes.

Who Should Seek Diagnostic Testing and When

Women experiencing certain warning signs should not delay seeking medical evaluation. The most common symptom that prompts diagnostic testing is unusual vaginal bleeding, which can appear in different ways depending on your stage of life. If you are past menopause, any vaginal bleeding or spotting, even a very slight amount, warrants immediate medical attention. This includes thin, watery discharge that may seem minor but could signal a problem.^[1][6]

For women who have not yet reached menopause, bleeding between your regular periods is a warning sign that should not be ignored. If you are over 40 years old and notice that your periods have become extremely heavy, prolonged, or occur more frequently than usual, it is advisable to consult your healthcare provider. Lower abdominal pain or cramping in the pelvic area, particularly when combined with unusual bleeding, is another reason to seek evaluation.^[8][6]

The symptoms of endometrial cancer can resemble those of many other conditions affecting reproductive organs, which is why an accurate diagnosis through proper testing is so important. Early diagnosis significantly improves your outlook, as the majority of women are diagnosed with stage 1 or stage 2 disease, and earlier detection leads to better treatment outcomes.^[1]

Methods Used to Diagnose Stage I Endometrial Cancer

Pelvic Examination

The diagnostic process typically begins with a thorough pelvic examination. During this examination, your healthcare provider carefully inspects the outer genital area and uses their hands to feel your internal reproductive organs. The doctor inserts two fingers into the vagina while pressing down on your abdomen with the other hand to check the size, shape, and position of your uterus and ovaries. A device called a speculum, which is a tool that gently opens the vaginal canal, allows the provider to look inside and check for visible abnormalities.^[10][23]

While a pelvic exam is an important first step, it cannot definitively diagnose endometrial cancer on its own. The exam helps your doctor determine whether further testing is needed and can rule out other conditions that might be causing your symptoms.

Imaging Tests

Imaging procedures create pictures of the inside of your body and help your medical team understand the location and size of any abnormal tissue. One of the most common imaging tests for suspected endometrial cancer is a transvaginal ultrasound. During this procedure, a healthcare professional inserts a wand-like device called a transducer into your vagina while you lie on an exam table. The transducer sends out sound waves that bounce off your internal organs and create images of your uterus and surrounding structures.^[10][23]

The transvaginal ultrasound allows doctors to examine the thickness of the endometrium, which is the inner lining of your uterus. An abnormally thick endometrial lining may indicate the presence of cancer or other conditions that require further investigation. This test is painless and does not use radiation, making it a safe first-line imaging option.

Tissue Sampling: Biopsy and Hysteroscopy

The definitive way to diagnose endometrial cancer is by examining tissue from the uterine lining under a microscope. This requires removing a small sample of tissue, which can be done in different ways. An endometrial biopsy is often performed in your doctor’s office. During this procedure, a thin tube is inserted through the cervix into the uterus to collect a sample of the endometrial lining. The tissue is then sent to a laboratory where specialists called pathologists, who are doctors trained to analyze tissues and identify disease, examine it under a microscope to look for cancer cells.^[1]

In some cases, your doctor may recommend a hysteroscopy, which provides a direct view inside your uterus. During this procedure, a thin, lighted instrument called a hysteroscope is inserted through the vagina and cervix into the uterus. The hysteroscope allows the doctor to visually inspect the uterine lining and take targeted tissue samples from any areas that look abnormal. This procedure may be performed in an office setting or in an outpatient surgical center, depending on your specific situation.^[10][23]

Staging Procedures

If the biopsy confirms the presence of endometrial cancer, additional procedures are needed to determine the stage, which describes how far the cancer has spread. For stage I endometrial cancer, the tumor is limited to the uterus and has not spread to other organs. However, determining the exact substage requires detailed information that is often only available after surgery.^[1]

The process of surgical staging involves examining tissue collected during the operation that removes the cancer. During this surgery, the tissue is carefully analyzed under a microscope to determine whether the cancer has grown into the muscular wall of the uterus and, if so, how deeply. This information helps classify the cancer as stage 1A, 1B, or 1C. Stage 1A means the tumor is either found only in the endometrium itself or has grown less than halfway into the muscle layer, and the cancer cells look less aggressive under the microscope. Stage 1B indicates that nonaggressive cancer has grown at least halfway into the muscle layer.^[1]

If surgery is not immediately possible due to other health conditions, your doctor will determine a clinical stage based on the results of your physical examination, imaging tests, and biopsy. This helps guide initial treatment decisions until more definitive staging can be performed.

Systems Used for Classification

Cancer specialists, called oncologists, use two main systems to classify endometrial cancer: the American Joint Committee on Cancer TNM system and the International Federation of Gynecology and Obstetrics (FIGO) system. Both systems rely on three key pieces of information, represented by the letters TNM. The letter T stands for tumor size and extent, meaning which tissues and organs are affected. The letter N indicates whether the cancer has spread to nearby structures called lymph nodes, which are small bean-shaped organs that are part of your immune system. The letter M refers to metastasis, which means spread to distant parts of the body.^[1]

Understanding these classification systems helps doctors communicate clearly about your diagnosis and determine the most appropriate treatment plan for your specific situation.

Diagnostic Testing for Clinical Trial Enrollment

When considering participation in a clinical trial for stage I endometrial cancer, specific diagnostic criteria must be met to ensure that the study enrolls appropriate patients and generates reliable results. Clinical trials test new treatments or compare different treatment approaches, and they require precise knowledge of each participant’s disease characteristics.

To qualify for most clinical trials focused on early-stage endometrial cancer, patients must have their diagnosis confirmed through tissue examination by a pathologist. The surgical removal of the uterus and examination of surrounding tissues provides the detailed staging information that clinical trials require. This includes knowing the exact depth of cancer invasion into the muscle wall of the uterus, whether lymph nodes contain cancer cells, and the grade of the cancer, which describes how abnormal the cells look under the microscope.^[1][4]

Some clinical trials specifically enroll patients with low-risk stage 1A disease, which might be defined as well-differentiated tumors with less than 50 percent invasion into the muscle wall. Other trials may focus on intermediate or high-risk early-stage disease, requiring confirmation of deeper invasion or more aggressive cell types. The molecular characteristics of the tumor, determined through laboratory analysis of cancer tissue, may also influence trial eligibility. Some studies examine specific gene changes or mutations in the cancer cells to match patients with targeted therapies designed to work against those particular genetic alterations.^[4]

Before enrolling in a clinical trial, participants typically undergo additional imaging tests beyond those used for initial diagnosis. These may include computed tomography (CT) scans or magnetic resonance imaging (MRI) to ensure that cancer has not spread beyond the uterus. Blood tests checking overall health, kidney function, liver function, and blood cell counts are standard requirements, as clinical trials need to ensure that participants are healthy enough to tolerate the experimental treatments being studied.

The documentation required for clinical trial enrollment is more extensive than for standard treatment. Complete surgical reports, detailed pathology reports including information about tumor grade and molecular features, and comprehensive imaging studies must all be available for review by the research team. This thorough diagnostic information ensures that the trial results will be meaningful and that patients receive treatments appropriate for their specific type and stage of cancer.